Mark C. Johnson, Cfa
About Mark C. Johnson, Cfa
Mark C. Johnson, CFA, serves as the Vice President and Head of Investor Relations at Prothena Corporation plc. He has over 20 years of experience in the life science and technology sectors, with a strong background in investor relations and corporate planning.
Current Role at Prothena
Mark C. Johnson serves as the Vice President and Head of Investor Relations at Prothena Corporation plc. He has held this position since 2023. In this role, he develops integrated communications strategies that engage analysts, investors, bankers, and other stakeholders. His expertise in investor relations is crucial for fostering relationships and ensuring effective communication between the company and its financial community.
Previous Experience in Investor Relations
Prior to his current role, Mark C. Johnson accumulated extensive experience in investor relations across various organizations. He worked at ACADIA Pharmaceuticals Inc. as Vice President of Investor Relations from 2019 to 2023 and as Senior Director of Investor Relations from 2018 to 2019. He also held positions at aTyr Pharma and SoftBank Group International, where he served as Senior Director and Director of Investor Relations, respectively. His background includes significant roles at MediciNova, Inc., where he advanced from Associate to Director of Investor Relations and Corporate Development.
Educational Background
Mark C. Johnson earned his Master of Business Administration (MBA) from the Rady School of Management at the University of California, San Diego, completing his studies from 2010 to 2012. He also holds a Bachelor of Arts in Economics from Cornell University, where he studied from 1999 to 2003. Additionally, he is pursuing a Certificate in Finance at UC San Diego, which he began in 2009.
Skills and Expertise
Mark C. Johnson possesses a diverse skill set that includes strategic planning, budgeting, and analysis, which support high-level business decisions at the Board level. He has expertise in negotiating and executing successful equity and debt financings, as well as mergers and acquisitions (M&A) transactions. His experience spans approximately 20 years in the life sciences and technology industries, emphasizing his capability in corporate planning and investor relations.
Career Progression
Mark C. Johnson's career began at MediciNova, Inc., where he held various roles from 2003 to 2013, including Associate in Business Development and Senior Manager in Corporate Planning. He transitioned to DeNA as Director of Investor Relations in 2013, followed by a position at SoftBank Group International. His trajectory continued with roles at aTyr Pharma and ACADIA Pharmaceuticals Inc. before joining Prothena Corporation plc. This progression highlights his sustained focus on investor relations and corporate planning within the life sciences sector.